Brief: Illumina Q4 Adjusted EPS USD 0.14 Vs. IBES Estimate USD 0.02
Feb 08 (Reuters) - Illumina Q4 adjusted gross margin 64.4%. * Q4 gross margin 60.1% * Q4 adjusted net income USD 22 million vs. IBES estimate USD 2.92 million * Q4 net income USD -176 million * Q4 EPS USD -1.11
Recent news on Illumina
See all newsRoche takes aim at Illumina's dominance with new gene sequencing machine (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner